Apollo Hospitals Enterprise Limited
APOLLOHOSP
주식 순위
#1778
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
주가
$83.93
시가총액
$12.07B
변동 (1일)
-1.23%
변동 (1년)
-7.79%
국가
IN
거래 Apollo Hospitals Enterprise Limited (APOLLOHOSP)
카테고리
Healthcare
Apollo Hospitals Enterprise Limited (APOLLOHOSP)의 P/E 비율
October 2026 기준 P/E 비율 TTM: 54.65
Apollo Hospitals Enterprise Limited의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 54.65입니다. 2024년 말 기준 P/E 비율은 103.32였습니다.
Apollo Hospitals Enterprise Limited의 P/E 비율 기록 (2005 ~ 2026)
매년 말 P/E 비율
| 연도 | P/E 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 54.65 | -17.13% |
| 2025 | 65.95 | -36.17% |
| 2024 | 103.32 | 36.54% |
| 2023 | 75.67 | 23.02% |
| 2022 | 61.51 | -77.23% |
| 2021 | 270.18 | 675.57% |
| 2020 | 34.84 | -53.44% |
| 2019 | 74.82 | -42.50% |
| 2018 | 130.12 | 77.39% |
| 2017 | 73.35 | 28.30% |
| 2016 | 57.17 | -0.79% |
| 2015 | 57.63 | 38.45% |
| 2014 | 41.62 | 7.29% |
| 2013 | 38.80 | -1.09% |
| 2012 | 39.22 | 17.57% |
| 2011 | 33.36 | -0.96% |
| 2010 | 33.68 | 26.51% |
| 2009 | 26.63 | -18.22% |
| 2008 | 32.56 | 15.08% |
| 2007 | 28.29 | -44.09% |
| 2006 | 50.60 | 26.17% |
| 2005 | 40.10 | 0.00% |
유사 기업 또는 경쟁사의 P/E 비율
| 회사 | P/E 비율 | P/E 비율 차이 | 국가 |
|---|---|---|---|
| 15.70 | -71.27% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -80.97% |
US
|
|
| 32.07 | -41.32% |
SA
|
|
| 20.00 | -63.40% |
BR
|
P/E 비율 읽는 방법
P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.
P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.
양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.